Cancer Breakthroughs Continue with Three-Quarters Predicted to Survive in 20 Years

Those are the predictions of Sir Harpal Kumar, Chief Executive of Cancer Research UK. This will equate to a 15% drop in deaths, or 400,000 fewer deaths in the UK, each year. However, some of the harder-to-treat cancers such as pancreatic cancer and brain cancer are unlikely to see a dramatic change, unless there is a hard-to-predict breakthrough.

This comes as there has been further news of cancer research success. Surgeons have described new treatment for prostate cancer that has not yet spread as 'truly transformative'. The research was published in The Lancet Oncology after trials showed half the patients had no traces of cancer. The treatment was more directed and without the usual severe side effects. It uses a combination of lasers and a drug made from deep sea bacteria. The research came from the combined effort of University College London, the Weizmann Institute of Science in Israel and Steba Biotech.

For further information, please contact Paul Gershlick on 01923 919 320.